two women reviewing documents together

Supporting Product Approval

Planning for Approval

With rigorous and evolving payer evaluation criteria, challenging price negotiations and a dynamic competitive environment, manufacturers need to prepare their market access strategy early in the product life cycle and assess often to ensure optimal access.

At Evidera, PPD’s peri- and post-approval business, our global teams of industry leaders, former payers, policy experts, physicians and experienced strategists can help you navigate complex evidence requirements and anticipate and overcome payer barriers to achieve optimal price and access.

From synthesizing evidence, to modeling unobserved outcomes, to defining and communicating your product’s value story, we can help demonstrate the value of your product to a host of stakeholders.

0 +

products/therapies supported in the past year with peri- and post-approval research

0 +

payer submissions across 20+ countries in the past five years


developed evidence to reverse, fast-track and influence National Institute for Clinical Excellence (NICE) decisions across a variety of therapeutic areas


We incorporate the patient experience – their perspectives, preferences and insight – into key aspects of your research. From designing protocols, to enrollment and retention, to evaluating health outcomes, patient-centric data and information are essential to product development and approval, and ultimately, to a healthier world.

Our patient-centered experts span a variety of disciplines, including psychometrics, economics, decision analysis, epidemiology, biostatistics, psychology and public health, and can help answer your most challenging research questions. By engaging with patients and patient groups, we can illuminate the patient experience at various stages in your product’s life cycle and better inform your patient-focused drug development strategy.